posted on 2019-05-23, 00:00authored byKornelia J. Skowron, Thomas E. Speltz, Terry W. Moore
Given the ubiquity of the α-helix in the proteome, there has been much research in developing mimics of α-helices, and most of this research has been toward developing protein-protein interaction inhibitors. A common strategy for mimicking α-helices has been through the use of constrained, helical peptides. The addition of a constraint typically provides for conformational and proteolytic stability and, in some cases, cell permeability. Some of the most well-known strategies included lactam formation and hydrocarbon “stapling.” Beyond those strategies, there have been many recent advances in developing constrained peptides. The purpose of this review is to highlight recent advances in the development of new helix-stabilizing technologies, constraint diversification strategies, tether diversification strategies, and combination strategies that create new bicyclic helical peptides.
Funding
This work was funded by the University of Illinois Cancer Center (to T.W.M.). T.E.S. was funded by training grant T32AT007533, Office of the Director, National Institutes of Health (OD) and National Center for Complementary and Integrative Health (NCCIH).
History
Publisher Statement
This is the pre-peer reviewed version of the following article: Skowron, K. J., Speltz, T. E., & Moore, T. W. (2019). Recent structural advances in constrained helical peptides. Medicinal Research Reviews, 39(2), 749-770. doi:10.1002/med.21540, which has been published in final form at 10.1002/med.21540.
Citation
Skowron, K. J., Speltz, T. E., & Moore, T. W. (2019). Recent structural advances in constrained helical peptides. Medicinal Research Reviews, 39(2), 749-770. doi:10.1002/med.21540